Shove Back
Then Pounce on Inefficiencies
Dear Bottarelli Research Member,
In the last three days, the blue chips have given up nearly 400 points. Without question, this is a brutally devastating wipeout, fueled by the escalating conflict and uncertainty in the Middle East.
For the second day, Israel has blasted Lebanon — dropping bombs on critical access roads, power stations, communications infrastructure, and the Beirut airport. This news has created a downward snowball effect that’s affected everything — from International markets to oil prices to inflation fears. There’s no question in my mind that without the Middle East conflict, the recent downtrend would not have happened at such an accelerated level, but that’s now irrelevant. Tactically speaking, we need to absorb the recent market environment and strategically decipher a plan that allows us to profit within the madness. So here’s the plan:
It may sound cliché, but the first step is not to panic. When I look at our longer-term upside positions, I think we have a well-diversified mix of companies with strong upside potential.
Barrick Gold offers us “safe haven” exposure to the gold sector via the ABX October 30 Calls (ABX JF).This can be seen today, as ABX is one of the only stocks on my ticker in the green.
Alliant Techsystems offers us exposure to the best mid-cap defense company via the ATK November 80 Calls (ATK KP), which is a smart position to have in times of missile scares and international conflict.
Caterpillar offers us exposure to the strongest blue chip you can buy via the November 75 Calls (CAT KO). With strong earnings, a loaded backlog, and exploding demand for international infrastructure (brought about by non-stop population growth), CAT looks poised to run for years to come.
Celgene offers us exposure to the resurgent biotech sector via the October 50 Calls (LQH JJ). Assuming the role of the most promising biotech company on the market, CELG should be a company you accumulate on any significant dips (just like we did with DNA). This additional accumulation may come as early as Monday.
Over on the put side, we’re holding the Medtronic August 50 Puts (MDT TJ) which have used today’s down-stroke to trade back in the black. A slew of earnings reports and forecasts from competitors, coupled with slowing growth for medical devices and FDA recalls, has cast a shadow on MDT that seems like it could last a while.

We also used today’s continuous downside on FedEx to exit the FDX July 100 Puts (FDXST) at our $0.15 sell price. While it doesn’t seem like much, this sell trigger could have gotten you to break-even (or even profitable) on our FDX earnings strangle.

As I mentioned yesterday, it may also be a good idea to enter into some additional puts on companies like WebMD Health (WBMD – NASDAQ), which carry sky-high price multiples within a NASDAQ index that’s approaching new 52-week lows. If you look at WBMD today, you can see the stock has a lot of room to move down. We could establish a put position as early as Monday.

But the most important rule in times like this is to simply shove back from the table. There’s no need trying to make rational trading decisions within an otherwise irrational market environment. Let’s simply watch the weekend developments while lining up a list of potential trading candidates that have gone down too much — like 3M (MMM — NYSE).

Then, once all the dust has settled, we’ll be ready to pounce on all the inefficiencies brought about by the last three days of extreme downside. Until then…
Lock and load
Sincerely,

© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.
Bottarelli Research alerts contain time-sensitive information, and are published and distributed to members with urgency. Because of this, not all published materials can be adequately proofread, and an occasional spelling or grammar error may exist.
Your Holiday-Shortened Update
DNA Moving on Approval
ATK Playing Defense
Setting Up Next Week
Take PEP Profits
Three “Bloated” Techs
Second Exit on PEP
Your Wednesday Update
Looking for Hammers
Shove Back
Three New Puts
Instant OIH Profits!
OIH Triggers at $9.10!
CDW Moving Lower
CDW Actually Beats
Dow Rallies 211 Points
MEDI’s Dreadful Quarter
Oil Services Remain Weak
CAT’s $1 Billion Profit
A Good Day to Be Long
Let’s Take Some Profits
End of Day Position Updates
Transports Get Jack-Hammered (again)
A Quick Downside Play
The Only Good Way for a Biotech to Spend Money
COF, Revisited
I Had this Cool Idea
The Incredible Difference in Post-Earnings Trading



